Lucis builds AI-powered preventative health insights for individuals using predictive analytics.
$20MSeries A
General Catalyst leading a $20M Series A for predictive health signals suggests the bar for clinical-grade AI validation is rising—this isn't a consumer wellness play, it's infrastructure for risk stratification. If you're building in adjacent health data spaces (genomics, wearables, claims), watch whether Lucis's model actually reduces downstream costs or just predicts them; that determines if payers fund the category or let it stay consumer-only.